Literature DB >> 14596889

Synergistic protection of PC12 cells from beta-amyloid toxicity by resveratrol and catechin.

Angela Conte1, Silvia Pellegrini, Davide Tagliazucchi.   

Abstract

beta-Amyloid peptide (beta-AP) elicits a toxic effect on neurons in vitro and in vivo. Many environmental factors including antioxidants, metal ions and proteoglycans modify beta-AP toxicity. We have investigated on PC12 cells, the protective effect from beta-AP (1-41) of two plant polyphenols, resveratrol and catechin. PC12 cells treated with 10(-6)M beta-AP (1-41) for 16h decrease the cell viability at 24% of the control with an IC(50) value of 1.1+/-0.14 x 10(-8)M. Twenty-five micromolar resveratrol and 50 microM catechin protect PC12 cells from beta-AP (1-41) toxicity with the IC(50) value increased at 2.2+/-0.19 x 10(-7)M and at 8.9+/-0.7 x 10(-8)M, respectively. While the protective effect is concentration dependent for catechin, resveratrol shows a concentration-dependent biphasic effect. Up to 50 microM concentration, resveratrol protects PC12 cells from beta-AP (1-41) toxicity. At concentration higher than 50 microM, an inhibitory activity on cell proliferation appears. This antiproliferative effect is shown also in the absence of beta-AP (1-41). Resveratrol and catechin have a synergistic protective action. In the presence of 50 microM catechin and 10 microM resveratrol or 25 microM resveratrol and 10 microM catechin, the toxicity determined by 10(-7)M beta-AP (1-41) is almost completely abolished. Catechin is more effective than resveratrol in protecting PC12 cells from the toxicity of hydrogen peroxide. The protection from Oxygen Reactive Species (ROS) toxicity is concentration dependent for both resveratrol and catechin. In this case the protection is merely additive and the synergistic effect is not observed. These results demonstrate that resveratrol and catechin protect PC12 cells from beta-AP (1-41) toxicity and that their protective effect is synergistic. Such a protective effect probably is not due only to their antioxidant activity. The different chemical and biological activity shown by these compounds on several cell types and the complexity of the beta-AP (1-41) toxicity may explain the synergistic protective effect and suggest that the utilization of different compounds with synergistic activity may protect more effectively from complex mechanisms of toxicity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14596889     DOI: 10.1016/j.brainresbull.2003.08.001

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  28 in total

1.  Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease.

Authors:  Saravanan S Karuppagounder; John T Pinto; Hui Xu; Huan-Lian Chen; M Flint Beal; Gary E Gibson
Journal:  Neurochem Int       Date:  2008-11-08       Impact factor: 3.921

Review 2.  SIRT1 in neurodevelopment and brain senescence.

Authors:  A Zara Herskovits; Leonard Guarente
Journal:  Neuron       Date:  2014-02-05       Impact factor: 17.173

3.  Resveratrol Induces Brain Resilience Against Alzheimer Neurodegeneration Through Proteostasis Enhancement.

Authors:  Rubén Corpas; Christian Griñán-Ferré; Eduard Rodríguez-Farré; Mercè Pallàs; Coral Sanfeliu
Journal:  Mol Neurobiol       Date:  2018-06-13       Impact factor: 5.590

4.  Combinatorial Preconditioning of Rat Brain Cultures with Subprotective Ethanol and Resveratrol Concentrations Promotes Synergistic Neuroprotection.

Authors:  N Khodaie; N Tajuddin; R M Mitchell; E J Neafsey; M A Collins
Journal:  Neurotox Res       Date:  2018-03-12       Impact factor: 3.911

5.  Effect of phenolic compounds against Aβ aggregation and Aβ-induced toxicity in transgenic C. elegans.

Authors:  Seema Jagota; Jayakumar Rajadas
Journal:  Neurochem Res       Date:  2011-08-21       Impact factor: 3.996

Review 6.  Targeting NADPH oxidase and phospholipases A2 in Alzheimer's disease.

Authors:  Agnes Simonyi; Yan He; Wenwen Sheng; Albert Y Sun; W Gibson Wood; Gary A Weisman; Grace Y Sun
Journal:  Mol Neurobiol       Date:  2010-03-02       Impact factor: 5.590

Review 7.  Resveratrol as a therapeutic agent for neurodegenerative diseases.

Authors:  Albert Y Sun; Qun Wang; Agnes Simonyi; Grace Y Sun
Journal:  Mol Neurobiol       Date:  2010-03-21       Impact factor: 5.590

8.  Green tea extract inhibits paraquat-induced pulmonary fibrosis by suppression of oxidative stress and endothelin-l expression.

Authors:  Hak-Ryul Kim; Byung-Kyu Park; Yeon-Mok Oh; Yun-Song Lee; Dong-Soon Lee; Hyun-Kuk Kim; Joo-Young Kim; Tae-Sun Shim; Sang-Do Lee
Journal:  Lung       Date:  2006 Sep-Oct       Impact factor: 2.584

Review 9.  Role of SIRT1 in autoimmune demyelination and neurodegeneration.

Authors:  Alvaro Martin; Cosmin A Tegla; Cornelia D Cudrici; Adam M Kruszewski; Philippe Azimzadeh; Dallas Boodhoo; Armugam P Mekala; Violeta Rus; Horea Rus
Journal:  Immunol Res       Date:  2015-03       Impact factor: 2.829

Review 10.  Botanical phenolics and brain health.

Authors:  Albert Y Sun; Qun Wang; Agnes Simonyi; Grace Y Sun
Journal:  Neuromolecular Med       Date:  2008-11-01       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.